The sudden, unexplained removal of a research paper on private equity firms buying dermatology practices has raised questions about corporate influence.
— Read on www.nytimes.com/2018/10/26/health/private-equity-dermatology.html
The sudden, unexplained removal of a research paper on private equity firms buying dermatology practices has raised questions about corporate influence.
— Read on www.nytimes.com/2018/10/26/health/private-equity-dermatology.html